CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 30, 2006--Gloucester Pharmaceuticals, Inc., a privately held cancer therapeutics development company, announced today that interim data from the Company’s pivotal trial of depsipeptide for cutaneous T-cell lymphoma will be presented at the 2006 Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held in Atlanta, GA June 2-6, 2006.
